They Just Don't Get...
Health Care: Drugs
Johnson & Johnson (JNJ: NYSE)
$65.19 -0.45 | -0.69%
02/06/12 - 04:00 PM ET
9.54M / 10.66M
Vol / Avg. Vol:65.46 / 65.64
Open / Prev. Close:65.05 - 65.58
Today's Range:57.50 - 68.05
52 Wk Range:-0.59%
Performance YTD:TheStreet Rating:
Portfolios with JNJ
- Portfolio NameUser Type
- UserStif
- UserW FRAZIER BRINLEY Portfolio 1
- Userchrisnash69 Portfolio 1
- User2012 BP Stocks
- UserNH (Beginner)
- Contributor10 Top Dividend Stocks to O...
- Userdividend
- UserIncome stocks
- UserTEST
- Userdiz
Latest JNJ Headlines from TheStreet
- They Just Don't Get Merck!
02.05.12 | 09:02 am - Merck's Lower Tax Rate 02.04.12 | 09:02 am
- Drugmakers Singing Same Song: 2012 Will Be Tough 02.02.12 | 04:02 pm
- Merck's Risky Cost Cutting Move 02.02.12 | 12:02 pm
- They Just Don't Get Merck! 02.02.12 | 11:02 am
- Dow Today: Johnson & Johnson (JNJ) Higher 02.01.12 | 12:02 pm
- Medivation's Prostate Cancer Drug: Survival Benefit With Low Seizure Risk 01.31.12 | 05:01 pm
- 2 Execs Out At J&J's Troubled Consumer Business 01.31.12 | 03:01 pm
- 3 Stocks I Saw on TV, January 30 01.30.12 | 07:01 am
- Stocks End Lower as Housing, Jobs Data Disappoint 01.26.12 | 04:01 pm
Press Releases for JNJ
- Biosense Webster Completes Enrollment In Ground-Breaking SMART-AF Trial - Business Wire 01.11.12 | 07:01 pm
- Biosense Webster Announces FDA Approval Of The THERMOCOOL® SF Catheter In The United States - Business Wire 01.11.12 | 07:01 pm
- Biosense Webster To Offer A Comprehensive Electrophysiology (EP) Lab Solution - Business Wire 01.10.12 | 04:01 pm
- Johnson & Johnson Announces First-Quarter 2012 Quarterly Dividend - PR Newswire 01.03.12 | 08:01 am
- Janssen Biotech, Inc. Announces Collaborative Development And Worldwide License Agreement For Investigational Anti-Cancer Drug, PCI-32765 - PR Newswire 12.08.11 | 04:12 pm
- Johnson & Johnson To Participate In The Piper Jaffray 23rd Annual Health Care Conference - PR Newswire 11.28.11 | 02:11 pm
- Johnson & Johnson To Participate In The Piper Jaffray 23rd Annual Health Care Conference - PR Newswire 11.22.11 | 10:11 am
- Economic Model Presented At ISPOR 2011 Suggests That The Use Of EXOSEAL Vascular Closure Device May Result In Important Cost Savings For U.S. Hospitals - Business Wire 11.08.11 | 08:11 pm
- Cordis EMPIRA™ And EMPIRA™ NC RX PTCA Dilatation Catheters Receive FDA Clearance - Business Wire 11.08.11 | 07:11 pm
- Steering Drivers In The Right Direction, "Healthy Vision⢠With Dr. Val Jones" Radio Show Offers Information, Advice About Driving In The Dark - PR Newswire 11.01.11 | 07:11 am
Partner Headlines for JNJ
- Dr. Reddy's Going Strong - Analyst Blog - Zacks 02.06.12 | 10:02 am
- The Zacks Analyst Blog Highlights: Alkermes plc, Elan, Johnson & Johnson, Amylin Pharmaceuticals and Eli Lilly & Company - Press Releases - Zacks 02.06.12 | 09:02 am
- The $27,000 Millionaire: Dividend Growth Unleashed - Seeking Alpha 02.05.12 | 07:02 am
- Earnings Scorecard: Johnson & Johnson - Analyst Blog - Zacks 02.03.12 | 06:02 pm
- Incivek Catalyst at Play for Vertex - Analyst Blog - Zacks 02.03.12 | 10:02 am
- Gilead Misses EPS Ests, Sales Up - Analyst Blog - Zacks 02.03.12 | 10:02 am
- Retirement Strategy: Time To Hold, Not Add (Part 9) - Seeking Alpha 02.03.12 | 08:02 am
- Merck Beats on EPS, Guides In-Line - Analyst Blog - Zacks 02.02.12 | 10:02 am
- 3 Donald Trump Stocks Worth Buying Now - Seeking Alpha 02.02.12 | 08:02 am
- Boston Scientific: Struggles Today, Still Hope For Tomorrow? - Seeking Alpha 02.02.12 | 08:02 am
